This inventor holds 1 USPTO granted patent. Top assignee: Neurocrine Biosciences, Inc.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: William R. Clevenger: Innovator in Interleukin-1 Type 3 Receptors
Introduction: William R. Clevenger is a notable inventor based in Vista, California. He has made significant contributions to the field of biotechnology, particularly in the development of Interleukin-1 Type 3 receptors. His work has implications for various therapeutic applications, showcasing the importance of innovation in medical science.
Latest Patents: Clevenger holds a patent for isolated nucleic acid molecules encoding soluble and membrane-bound forms of Interleukin-1 Type 3 receptors. This invention includes recombinant expression vectors and host cells suitable for expressing such receptors. His patent represents a crucial advancement in understanding and manipulating immune responses.
Career Highlights: Clevenger is currently associated with Neurocrine Biosciences, Inc., where he continues to contribute to groundbreaking research. His expertise in biotechnology and molecular biology has positioned him as a key figure in his field.
Collaborations: Some of his notable coworkers include Timothy W. Lovenberg and Tilman Oltersdorf. Their collaborative efforts enhance the research environment and foster innovation within the company.
Conclusion: William R. Clevenger's work exemplifies the vital role of inventors in advancing medical science through innovative patents. His contributions to the field of biotechnology are significant and continue to impact therapeutic developments.